JAC Advance Access published online on September 6, 2002
Journal of Antimicrobial Chemotherapy, doi:10.1093/jac/dkf179
© 2002 by The British Society for Antimicrobial Chemotherapy
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In Brief
1 Intensive Care Unit and
Trauma Center, Nord Hospital, Marseilles School of Medicine, Marseilles
* Corresponding author. E-mail: marc.leone{at}ap-hm.fr.
Received 18 February 2002
; revised 18 June 2002
; accepted 15 July 2002
Ciprofloxacin distribution was assessed in cerebral
tissues in 14 patients undergoing craniotomy. The study objective
was to determine the brain tissue/serum concentration ratio of ciprofloxacin.
Patients received a single intravenous (iv) 200 mg dose of ciprofloxacin.
Mean (± S.D.) tissue/serum concentration ratios were (mg/kg):
parietal fat during opening 1.40 ± 1.05, during
closure 1.34 ± 1.17, in the dura mater
2.26 ± 1.36, in skull bone during opening
0.44 ± 0.29, during closure 0.97 ± 1.57 and in brain tissue 0.88 ± 0.99. Mean (± S.D.) concentrations of ciprofloxacin
in brain tissue were 0.87 ± 0.08 mg/kg,
suggesting that a dose >200 mg iv ciprofloxacin is required
to ensure therapeutic concentrations in brain tissue.
Brain tissue penetration of ciprofloxacin following
a single
intravenous dose
2 Department of Pharmacokinetics,
Timone Hospital, France
3 Department
of Neurosurgery, Nord Hospital, Marseilles School of Medicine, Marseilles
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Brunner, O. Langer, G. Dobrozemsky, U. Muller, M. Zeitlinger, M. Mitterhauser, W. Wadsak, R. Dudczak, K. Kletter, and M. Muller [18F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3850 - 3857. [Abstract] [Full Text] [PDF] |
||||
